Conference abstract
?New? drugs and international regulatory mechanisms
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
?Th e big players? continue to dominate the medicinal scene and such parameters are important when ?incurable? diseases set in. Prevention rather than ?treatment? of diseases needs to be emphasized. Interactions between hitherto undetected disease causing proteins (?small players?) are being targeted, whereby newer and better drugs are awaited in the forthcoming era of personalized medicine. Anti-fungals based on ?Click? reaction have been developed by the author. Fift y fi ve years since the discovery of the last vitamin, Pyrroloquinoline quinone (PQQ) is now recognized as the 14 th vitamin. To be useful as a vitamin, it has to available at low cost. Th e author?s work on ?true nitrene? based homo and hetero bifunctional crosslinkers for proteomics and lipidomics could be useful for chemical crosslinking-mass spectrometry based rapid and reliable high throughput screening (HTS) of large number of samples routinely. Soluble Fullerenes and SWCNT developed in my laboratory have been shown to be compatible with blood for nano- drug delivery. Norms for drug approvals becoming very stringent worldwide, discovery of new drug entities has now become very diffi cult. As ways are found for overcoming these, many issues arise, which need to be adjudged in an equitable and fair manner. Serving as a ?Local Commisioner? in cases of drug fi rms at an international level has been a learning experience for the author. Th e use of modern instrumentation for regulatory purposes is to be strongly advocated. Open Source Drug Discovery (OSDD), a laudable initiative has also provided the author much needed stimulus
Subjects
Pharmaceutical SciencesAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Bioequivalence & Bioavailability
- SubjectPharmaceutical Sciences
- BylineArticles whose byline prints “S. V. Eswaran”